The above findings reveal the centrality of astrocyte lipid metabolism abnormalities in neurodegenerative diseases, and provide key therapeutic directions for targeting APOE4, regulation of LD dynamics and transcellular metabolic remodeling. Here, APOE is linked to neurodegenerative disease.